PKC-mediated phosphorylation and activation of the MEK/ERK pathway as a mechanism of acquired trastuzumab resistance in HER2-positive breast cancer

DSpace Repository

PKC-mediated phosphorylation and activation of the MEK/ERK pathway as a mechanism of acquired trastuzumab resistance in HER2-positive breast cancer

Author: Scerri, Jeanesse; Scerri, Christian; Schaefer-Ruoff, Felix; Fink, Simon; Templin, Markus; Grech, Godfrey
Tübinger Autor(en):
Fink, Simon
Schäfer-Ruoff, Felix
Templin, Markus F.
Published in: Frontiers in Endocrinology (2022), Bd. 13, Article 1010092
Verlagsangabe: Frontiers Media Sa
Language: English
Full text: http://dx.doi.org/10.3389/fendo.2022.1010092
ISSN: 1664-2392
DDC Classifikation: 610 - Medicine and health
Dokumentart: Article
Show full item record

This item appears in the following Collection(s)